Akebia Therapeutics Inc (AKBA)
EBITDA Margin
-8.37%
TTM · Period ending:
AKBA EBITDA Margin
Latest reported-8.37%period ending
Latest reported-8.37%period ending
AKBA TTM EBITDA Margin (-8870.62% → -8.37%)
TTM ebitda margin
High-resolution chart · PNG
AKBA ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| -8.3718% | |
| -2.4785% | |
| 9.1988% | |
| 9.4335% | |
| 5.4027% | |
| 2.5932% | |
| -8.9362% | |
| 2.1804% | |
| 2.3129% | |
| 1.4571% | |
| -4.2467% | |
| -1.2939% | |
| -19.7493% | |
| 1.6584% | |
| -9.4339% | |
| -31.4826% | |
| -32.9229% | |
| -94.7481% | |
| -102.4125% | |
| -102.6667% | |
| -100.2145% | |
| -122.5761% | |
| -105.495% | |
| -106.8454% | |
| -95.3556% | |
| -59.8173% | |
| -67.5628% | |
| -76.1737% | |
| -80.0198% | |
| -91.8551% | |
| -83.777% | |
| -32.2272% | |
| -32.3264% | |
| -28.9398% | |
| -44.5546% | |
| -139.6744% | |
| -276.6359% | |
| -691.9063% | |
| -8,870.6189% |